Literature DB >> 21538963

Group consensus review minimizes the diagnosis of "follicular lesion of undetermined significance" and improves cytohistologic concordance.

Xin Jing1, Stewart M Knoepp, Michael H Roh, Kim Hookim, Jeremiah Placido, Robertson Davenport, Rodolfo Rasche, Claire W Michael.   

Abstract

We conducted a group consensus review of thyroid aspirates that were previously interpreted as "atypia of undetermined significance/follicular lesion of undetermined significance" (AUS/FLUS) and followed by surgical interventions. The study aimed to investigate if consensus review would minimize the diagnosis of AUS/FLUS with an optimal interobserver agreement and also promote a better cytohistologic concordance. A group of reviewers who were blinded to the corresponding histologic findings simultaneously evaluated a total of 50 aspirates at a multiheaded light microscope. Using the Bethesda System for Reporting Thyroid Cytopathology as a guideline, a consensus interpretation was reached upon review of each aspirate. Interobserver agreement was calculated and recorded. The cytohistologic correlation was then performed between the consensus interpretation and the corresponding histologic diagnosis. The consensus review reclassified 26 (52%) aspirates as non-neoplasia/benign, 10 (20%) as follicular neoplasm/suspicious for a follicular neoplasm, 1 (2%) as papillary thyroid carcinoma, and 2 (4%) as nondiagnostic. Eleven (22%) aspirates remained AUS/FLUS. The interobserver agreement across the five diagnostic categories ranged from 71.6% to 100% with an average level of 88.8%. Cytohistologic concordance was achieved in 24 of 26 (92.3%) and 9 of 11 (81.8%) aspirates that were reclassified as non-neoplasia/benign and neoplasia/malignancy, respectively. A diagnostic accuracy of 89.2% (33/37) was obtained in reclassified cases. In conclusion, the group consensus review minimized AUS/FLUS, offered an optimal level of interobserver agreement, and most importantly, promoted excellent cytohistologic concordance in reclassified cases and, therefore, could play a substantial role in the future in reducing reaspiration and/or unnecessary surgeries.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21538963     DOI: 10.1002/dc.21702

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  7 in total

1.  Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological Approach.

Authors:  Pablo Valderrabano; Laila Khazai; Zachary J Thompson; Marino E Leon; Kristen J Otto; Julie E Hallanger-Johnson; J Trad Wadsworth; Bruce M Wenig; Christine H Chung; Barbara A Centeno; Bryan McIver
Journal:  Thyroid       Date:  2017-09-14       Impact factor: 6.568

2.  Ultrasound-guided core-needle biopsy in thyroid nodules. A study of 676 consecutive cases with surgical correlation.

Authors:  Miguel Paja; Jose L del Cura; Rosa Zabala; Igone Corta; Aitzol Lizarraga; Amelia Oleaga; Amaia Expósito; M Teresa Gutiérrez; Aitziber Ugalde; José I López
Journal:  Eur Radiol       Date:  2015-05-10       Impact factor: 5.315

3.  A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology.

Authors:  Lei Zhang; Thomas Krausz; Richard M DeMay
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-08

4.  Thyroid Imaging Reporting and Data System Score Combined with the New Italian Classification for Thyroid Cytology Improves the Clinical Management of Indeterminate Nodules.

Authors:  Salvatore Ulisse; Daniela Bosco; Francesco Nardi; Angela Nesca; Eleonora D'Armiento; Valeria Guglielmino; Corrado De Vito; Salvatore Sorrenti; Daniele Pironi; Francesco Tartaglia; Stefano Arcieri; Antonio Catania; Massimo Monti; Angelo Filippini; Valeria Ascoli
Journal:  Int J Endocrinol       Date:  2017-03-01       Impact factor: 3.257

5.  Cytomorphological Categorization of Thyroid Lesions according to The Bethesda System for Reporting Thyroid Cytology and Correlation with their Histological Outcome: An Indian Oncology Centre Experience.

Authors:  Meenakshi Kamboj; Anurag Mehta; Sunil Pasricha; Gurudutt Gupta; Anila Sharma; Garima Durga
Journal:  J Cytol       Date:  2022-01-31       Impact factor: 1.000

Review 6.  Evaluation and Management of Indeterminate Thyroid Nodules: The Revolution of Risk Stratification Beyond Cytological Diagnosis.

Authors:  Pablo Valderrabano; Bryan McIver
Journal:  Cancer Control       Date:  2017 Oct-Dec       Impact factor: 3.302

7.  Low reproducibility of equivocal categories of the Bethesda System for Reporting Thyroid Cytology makes the associated risk of malignancy specific to the diagnostic center.

Authors:  Dorota Słowińska-Klencka; Mariusz Klencki; Joanna Duda-Szymańska; Jarosław Szwalski; Bożena Popowicz
Journal:  Endocrine       Date:  2021-06-12       Impact factor: 3.633

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.